Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Nov. 9, 2020, at 4:15 p.m. ET in Scottsdale, Ariz. Key executives, Murdo Gordon and Peter H. Griffith, will be representing the company. Investors can listen to the live audio on Amgen's website, with a replay available for 90 days. Founded in 1980, Amgen focuses on addressing unmet medical needs through innovative therapies and advanced human genetics. For more details, visit www.amgen.com.

News Market Reaction – AMGN

+0.71%

+0.71% Session move

In the trading session that priced this news, AMGN gained 0.71%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., Nov. 4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 29th Annual Credit Suisse Virtual Healthcare Conference at 4:15 p.m. ET on Monday, Nov. 9, 2020, in Scottsdale, Ariz. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith, executive vice president and chief financial officer, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors)

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-29th-annual-credit-suisse-healthcare-conference-301166676.html

SOURCE Amgen

FAQ

When will Amgen present at the Credit Suisse Healthcare Conference?

Amgen will present at the Credit Suisse Virtual Healthcare Conference on November 9, 2020, at 4:15 p.m. ET.

Who will be representing Amgen at the conference?

Murdo Gordon and Peter H. Griffith will represent Amgen at the conference.

How can I access Amgen's presentation at the conference?

The presentation can be accessed live via Amgen's website, with a replay available for 90 days.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on unlocking the potential of biology to address unmet medical needs and improve health outcomes.

What is the stock symbol for Amgen?

The stock symbol for Amgen is AMGN.